ROLE OF MONOCLONAL ANTIBODIES IN CLINICAL RESEARCH AND THERAPY- A REVIEW
Journal Title: World Journal of Pharmaceutical and life sciences - Year 2017, Vol 3, Issue 3
Abstract
Antibodies are natural proteins with modular structure, specific pharmacodynamics and pharmacokinetics and possibly produced against any antigens, thus giving them several advantages over small drug therapeutics. Monoclonal antibodies (mAb) have been applied to the diagnosis and therapy of an array of human diseases. They are a novel and promising therapeutic class used with great results in inflammatory diseases such as rheumatoid arthritis. The initial failures of early clinical trials have been overcome through the production of a new generation of mAb which features reduced immunogenicity and improved targeting abilities. The early models of mAb therapy were focused on enhancing the cytolytic mechanisms against the tumor cells. More recently, successful mAb-based therapies were targeted to molecules involved in the regulation of growth of cancer cells. Despite all the difficulties, clinical data is outlining an increasingly significant role for antibody-mediated cancer therapy as a versatile and powerful instrument in cancer treatment. Lung cancer is the leading cause of cancer-related deaths in industrialized countries and non small cell lung cancer (NSCLC) accounts for 85% of all lung cancers. It seems that mAbs therapy in NSCLC clearly marks the start of a new era in NSCLC treatment, with promise in improving patient survival and quality of life. Monoclonal antibodies (MAbs) are an old immunological tool with applications in the fields of immunology, biotechnology, biochemistry, and applied biology. Recently, MAbs have been widely applied in the field of clinical medicine. Currently, MAbs account for one-third of all the new therapeutic treatments for breast cancer, leukemia, arthritis, transplant rejection, asthma, and psoriasis, with many more late-stage clinical trials being conducted. In this review, we outline the (i) production of MAbs, (ii) application of MAbs, (iii) antibody engineering, and (iv) pharmaceutical application of MAbs.
Authors and Affiliations
Nithin Manohar
Keywords
Related Articles
- EP ID EP648990
- DOI -
- Views 204
- Downloads 0
INDUCION, MODE OF ACTION AND APPLICATIONS OF INTERFERON FOR TREATMENT OF VARIOUS HUMAN DISEASES: A REVIEW
Interferons are member of cytokines family that alter a broad range of cellular activities. These are low molecular weight, host encoded proteins or glycoproteins that induce a series of interferon stimulated genes that...
EVALUATION OF EFFECTIVENESS OF TAGETES ERECTA EXTRACT IN CONTROLLING CITRUS NEMATODE TYLENCHULUS SEMIPENETRANS IN WASIT PROVINCE
The study has been conducted in the laboratory of college of science – university of wasit in cooperation with the ministry of science and technology- directorate of agriculture research to evaluate the effect plant extr...
ANTIULCEROGENIC AND ANTIOXIDATIVE EFFECTS OF AQUEOUS EXTRACT OF CHROMOLAENA ODORATA L. (KING AND ROBINSON)
This study aimed to evaluate the antiulcer and antioxidative effects of aqueous extract of C.odorata. The antiulcer effect was evaluated in the mice and rat by using HCl/ethanol mixture, ethanol (EtOH) and the indometaci...
ROLE OF MONOCLONAL ANTIBODIES IN CLINICAL RESEARCH AND THERAPY- A REVIEW
Antibodies are natural proteins with modular structure, specific pharmacodynamics and pharmacokinetics and possibly produced against any antigens, thus giving them several advantages over small drug therapeutics. Monoclo...
STANDARDISATION OF MURUKKAN VITAI MATHIRAI- A SIDDHA TABLET FORMULATION
Herbal medicine has been commonly used over the years for treatment and prevention of diseases, health promotion and enhancement of the span and quality of life. There is lack of a systematic approach to assess their saf...